34 results
Thumbnail

D1.264 - Assessment by general practitioners of a therapeutic patient education guide for allergic patients

Thumbnail

D1.262 - Clinical significance of a basophil activation test for Japanese beekeepers naturally sensitized to honey bee venom

Thumbnail

D1.265 - Component-Resolved Diagnosis and Clinical Profiles of Anisakis Allergy in Japan

Thumbnail

D1.266 - Investigation of anaphylaxis in mastocytosis mouse models

Thumbnail

D1.267 - Recurrence of perioperative anaphylaxis: analysis of a multicenter cohort

Thumbnail

D1.268 - The endothelial glycocalyx as a therapeutic target in anaphylaxis

Thumbnail

D1.269 - Deciphering cardiovascular profiles in sera and extracellular vesicles from anaphylactic patients. Impact in endothelial cells

Thumbnail

D1.270 - Anaphylaxis and Adrenaline: Knowledge gaps with critical consequences

Thumbnail

D1.271 - Bovine gelatine-induced anaphylaxis brought on by eating beef, sweets containing gelatin, and medications

Thumbnail

D1.272 - Efficacy and Safety of Omalizumab in Treating Severe Allergic Reactions with Urticaria as the Initial Symptom

Thumbnail

D1.273 - Anaphylactic Reaction Following Sulphur Hexafluoride Administration

Thumbnail

D2.150 - Safety and efficacy of a 7-week immunotherapy protocol with aluminum hydroxide adsorbed bee venom

Thumbnail

D2.159 - Real-World Protective Effects of Epicutaneous Immunotherapy in Peanut-allergic Toddlers

Thumbnail

D2.149 - EFFECTIVENESS AND SAFETY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY WITH Pru p3 EXTRACT IN PATIENTS WITH LTP ALLERGY

Thumbnail

D2.151 - Study design for A multicenter, open label, randomized Study to inveStigate the effIcacy of Subcutaneous immunoTherapy combined with vitamin D3 in children and adolescent patients with allergic rhinitis (ASSIST study)

Thumbnail

D2.152 - Study design for the effect of SCIT on tic symptoms in Children and Adolescents with HDM aLlergy and coMorbid tic disorders: a multicenter prospective observational study (CALM study)

Thumbnail

D2.153 - Allergenicity and Immunogenicity of Polypeptide-Conjugated Hepatitis B Core Antigen Virus‐Like-Particle (HBcAg-VLP) Vaccine for Treatment of Shellfish Allergy

Thumbnail

D2.154 - Real-life observational study on the effectiveness of a broad-spectrum allergen product in unresponsive pediatric patients

Thumbnail

D2.155 - Factors associated with higher serum IgG4 response in children treated with allergen immunotherapy

Thumbnail

D2.156 - Study on the Effect of the Mucosal Vaccine MV130 on Innate Immunity Factors in School-Age Children